vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and FIRST MID BANCSHARES, INC. (FMBH). Click either name above to swap in a different company.
FIRST MID BANCSHARES, INC. is the larger business by last-quarter revenue ($88.2M vs $44.9M, roughly 2.0× AbCellera Biologics Inc.). FIRST MID BANCSHARES, INC. runs the higher net margin — 26.8% vs -19.9%, a 46.8% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 3.4%). FIRST MID BANCSHARES, INC. produced more free cash flow last quarter ($124.0M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 5.0%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
First Mid Bancshares Inc. is a U.S.-headquartered regional financial services holding company. It provides full-range retail and commercial banking products, wealth management, insurance solutions, and agricultural financing, mainly serving individual consumers, small and medium-sized enterprises, and agricultural clients across multiple Midwestern states including Illinois, Missouri, and Indiana.
ABCL vs FMBH — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $88.2M |
| Net Profit | $-8.9M | $23.7M |
| Gross Margin | — | — |
| Operating Margin | -63.7% | 34.0% |
| Net Margin | -19.9% | 26.8% |
| Revenue YoY | 788.4% | 3.4% |
| Net Profit YoY | 73.9% | 23.5% |
| EPS (diluted) | $-0.03 | $0.98 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $88.2M | ||
| Q3 25 | $9.0M | $89.3M | ||
| Q2 25 | $17.1M | $87.5M | ||
| Q1 25 | $4.2M | $84.3M | ||
| Q4 24 | $5.0M | $85.3M | ||
| Q3 24 | $6.5M | $80.6M | ||
| Q2 24 | $7.3M | $79.2M | ||
| Q1 24 | $10.0M | $79.9M |
| Q4 25 | $-8.9M | $23.7M | ||
| Q3 25 | $-57.1M | $22.5M | ||
| Q2 25 | $-34.7M | $23.4M | ||
| Q1 25 | $-45.6M | $22.2M | ||
| Q4 24 | — | $19.2M | ||
| Q3 24 | $-51.1M | $19.5M | ||
| Q2 24 | $-36.9M | $19.7M | ||
| Q1 24 | $-40.6M | $20.5M |
| Q4 25 | -63.7% | 34.0% | ||
| Q3 25 | -851.8% | 32.2% | ||
| Q2 25 | -290.2% | 34.4% | ||
| Q1 25 | -1479.6% | 33.4% | ||
| Q4 24 | — | 29.7% | ||
| Q3 24 | -1439.4% | 31.5% | ||
| Q2 24 | -1276.2% | 33.7% | ||
| Q1 24 | -551.5% | 33.7% |
| Q4 25 | -19.9% | 26.8% | ||
| Q3 25 | -637.8% | 25.2% | ||
| Q2 25 | -203.3% | 26.8% | ||
| Q1 25 | -1077.2% | 26.3% | ||
| Q4 24 | — | 22.5% | ||
| Q3 24 | -785.4% | 24.2% | ||
| Q2 24 | -504.3% | 24.9% | ||
| Q1 24 | -408.0% | 25.6% |
| Q4 25 | $-0.03 | $0.98 | ||
| Q3 25 | $-0.19 | $0.94 | ||
| Q2 25 | $-0.12 | $0.98 | ||
| Q1 25 | $-0.15 | $0.93 | ||
| Q4 24 | — | $0.81 | ||
| Q3 24 | $-0.17 | $0.81 | ||
| Q2 24 | $-0.13 | $0.82 | ||
| Q1 24 | $-0.14 | $0.86 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | — |
| Total DebtLower is stronger | — | $354.5M |
| Stockholders' EquityBook value | $966.9M | $958.7M |
| Total Assets | $1.4B | $8.0B |
| Debt / EquityLower = less leverage | — | 0.37× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | — | ||
| Q3 25 | $83.2M | — | ||
| Q2 25 | $92.4M | — | ||
| Q1 25 | $159.3M | — | ||
| Q4 24 | $156.3M | — | ||
| Q3 24 | $126.6M | — | ||
| Q2 24 | $148.3M | — | ||
| Q1 24 | $123.6M | — |
| Q4 25 | — | $354.5M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $966.9M | $958.7M | ||
| Q3 25 | $964.0M | $932.2M | ||
| Q2 25 | $1.0B | $894.1M | ||
| Q1 25 | $1.0B | $870.9M | ||
| Q4 24 | $1.1B | $846.4M | ||
| Q3 24 | $1.1B | $858.5M | ||
| Q2 24 | $1.1B | $813.6M | ||
| Q1 24 | $1.1B | $798.0M |
| Q4 25 | $1.4B | $8.0B | ||
| Q3 25 | $1.4B | $7.8B | ||
| Q2 25 | $1.4B | $7.7B | ||
| Q1 25 | $1.3B | $7.6B | ||
| Q4 24 | $1.4B | $7.5B | ||
| Q3 24 | $1.4B | $7.6B | ||
| Q2 24 | $1.4B | $7.6B | ||
| Q1 24 | $1.5B | $7.7B |
| Q4 25 | — | 0.37× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $130.9M |
| Free Cash FlowOCF − Capex | $-44.6M | $124.0M |
| FCF MarginFCF / Revenue | -99.4% | 140.6% |
| Capex IntensityCapex / Revenue | 21.9% | 7.8% |
| Cash ConversionOCF / Net Profit | — | 5.53× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $207.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $130.9M | ||
| Q3 25 | $-52.6M | $33.0M | ||
| Q2 25 | $-32.4M | $7.7M | ||
| Q1 25 | $-11.6M | $47.9M | ||
| Q4 24 | $-108.6M | $124.4M | ||
| Q3 24 | $-28.9M | $33.1M | ||
| Q2 24 | $-30.0M | $24.0M | ||
| Q1 24 | $-41.7M | $29.0M |
| Q4 25 | $-44.6M | $124.0M | ||
| Q3 25 | $-61.5M | $31.9M | ||
| Q2 25 | $-45.8M | $6.0M | ||
| Q1 25 | $-22.2M | $46.0M | ||
| Q4 24 | $-187.0M | $119.5M | ||
| Q3 24 | $-47.4M | $32.0M | ||
| Q2 24 | $-50.1M | $22.9M | ||
| Q1 24 | $-65.8M | $27.6M |
| Q4 25 | -99.4% | 140.6% | ||
| Q3 25 | -687.0% | 35.8% | ||
| Q2 25 | -267.9% | 6.8% | ||
| Q1 25 | -524.0% | 54.5% | ||
| Q4 24 | -3702.8% | 140.0% | ||
| Q3 24 | -728.4% | 39.7% | ||
| Q2 24 | -683.8% | 28.9% | ||
| Q1 24 | -661.5% | 34.5% |
| Q4 25 | 21.9% | 7.8% | ||
| Q3 25 | 99.7% | 1.2% | ||
| Q2 25 | 78.2% | 2.0% | ||
| Q1 25 | 251.1% | 2.3% | ||
| Q4 24 | 1552.7% | 5.8% | ||
| Q3 24 | 284.6% | 1.4% | ||
| Q2 24 | 274.6% | 1.4% | ||
| Q1 24 | 242.5% | 1.9% |
| Q4 25 | — | 5.53× | ||
| Q3 25 | — | 1.47× | ||
| Q2 25 | — | 0.33× | ||
| Q1 25 | — | 2.16× | ||
| Q4 24 | — | 6.49× | ||
| Q3 24 | — | 1.70× | ||
| Q2 24 | — | 1.21× | ||
| Q1 24 | — | 1.42× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
